TISSIUM
Created in 2013
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
683 10,942Global tags
Activities
Technologies
Entity types
Location
74 Rue du Faubourg Saint-Antoine, 75012 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 123
SIREN
793166299Engaged corporates
17
11 6Added in Motherbase
3 years, 7 months ago
biotech Value proposition
Biomorphic Programmable Polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Medical Device, MedTech, Synthetic Polymers, Tissue Reconstruction, and InnovationOriginal language
Biomorphic Programmable Polymers
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.
We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
Tissue Reconstruction Solutions | TISSIUM Biomorphic Programmable Polymers
TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.
https://tissium.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 La French Tech Bourgogne-Franche-Comté French Tech, Non-profit Organizations | La French Tech Bourgogne-Franche-Comté French Tech, Non-profit Organizations | Other 2 Sep 2024 | | |
 Crédit Mutuel Bank, Banking | Crédit Mutuel Bank, Banking | Other 18 Jul 2024 | | |
 Start Industrie Non-profit Organizations | Start Industrie Non-profit Organizations | Other 22 May 2024 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 19 Nov 2023 | | |
 KLESIA Insurance | KLESIA Insurance | Other 12 Jun 2023 13 Jul 2023 | | |
 CMA CGM Transportation, Logistics, Supply Chain and Storage | CMA CGM Transportation, Logistics, Supply Chain and Storage | Other 16 Apr 2023 | | |
 Ministry of Economy Government Administration | Ministry of Economy Government Administration | Other 22 Feb 2023 | | |
 Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Karista Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 23 May 2024 | | |
 PYMNTS Online Audio and Video Media | PYMNTS Online Audio and Video Media | Other 21 Aug 2022 | | |
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 10 Oct 2022 | | |